Company: EHSI
Filing Date: 2025-09-02
Form Type: PRE 14A
Source: 0001437749-25-028137
Chunk: 24

Company: Elite Health Systems Inc.
Filing Date: 2025-09-02
Form: PRE 14A
Chunk 24
---
 |   265,000 |     |          |  1.2 |   |
| William St. Lawrence                                                   
 23 Ashland Street                                                      
 Newburyport, MA 01950                                                  |     |                           |   165,000 |     |          |    * |   |
| Dr. Haranath Policherla                                                
 936 Lakeshore Road                                                     
 Grosse Pointe Shores, MI 48236                                         |     |                           | 1,000,000 |     |          |  4.6 |   |
| Kenneth Minor                                                          
 S8749 Waters Edge Way                                                  
 Prairie du Sac, WI 53578                                               |     |                           |        __ |     |          |   __ |   |
| Allen & Company Incorporated                                           
 711 Fifth Avenue                                                       
 New York, NY 10022                                                     |     |                           | 1,578,489 |     |          |  7.2 |   |
| All current Executive Officers and Directors as a Group (6 persons)(2) |     |                           | 4,696,343 |     |          | 21.4 |   |

| * | less than 1% |

| (1) | Unless otherwise indicated, all shares are beneficially owned and sole voting and investment power is held by the person named above. |

| (2) | Includes 222,114 shares held by an entity of which Dr. Jeereddi is a managing member and a majority equity holder. |

| (3) | Includes 1,140,246 shares held jointly by Mr. Gold and his wife as joint tenants with right of survivorship. |

NARRATIVE DISCUSSION OF EXECUTIVE COMPENSATION

This Narrative Discussion of Executive Compensation describes our compensation strategy, policies, programs and practices for the executive officers identified in the Summary Compensation Table. Currently only our Chief Executive Officer is identified as a the “Named Executive Officer.”

The Company currently does not have a compensation committee and is not paying any cash compensation to our Chief Executive Officer nor has any contract with Dr. Jeereddi. Dr. Jeereddi was appointed CEO in July 2024 and awarded 250,000 options in January 2025 as compensation for his activities as Chief Executive Officer , the Board issued Dr. Jeereddi 250,000 shares of common stock as compensation for his services as Chief Executive Officer and Chairman of the Board for the year ended December 31,2024 and 375,000